INTRAMURAL RESEARCH PROJECT Z01 DK 55101-01 MCEB October 1, 1997-September 30, 1998 Title of Project: Molecular Mechanisms of Thyroid and Nuclear Hormone Receptor Action Principal Investigator: P.M. Yen, M.D. (Investigator) MCEB, NIDDK, NIH Bethesda, MD 20892 Other Personnel: S. Ando, M.D. Ph.D. X. Feng, Ph.D. Y. Liu, M.A., M.D. P. Maruvada, Ph.D. P. Rotman, M.D. J. Palmer-East, B.A. Collaborating Units: None Staff-Years: 5.0 Human Subjects: Neither human subjects or tissues Summary of Work: Thyroid hormone receptors (TRs) belong to a superfamily of nuclear hormone receptors including the steroid hormone, vitamin D, and retinoid receptors. They can bind as heterodimers with retinoid X receptors to hormone response elements (HREs) located in the promoter region of target genes. For positively-regulated genes, thyroid hormone (T3) binds to the receptor and increases transcription. Interestingly, in the absence of T3, TRs can still bind to HREs and repress transcription below basal level. There is emerging evidence on how the receptor mediates these effects. Recently, several groups have described co-activators and co-repressors that interact with the receptor in a ligand- dependent manner. Additionally, there are other proteins that interact with the liganded receptor/co-activator complex such as CBP and p/CAF which have intrinsic histone acetylase activity. Similarly, co-repressors have been shown to complex with histone deactylases. Far-western and co-transfection studies from our group have suggested there are multiple proteins that can interact with both the unliganded and liganded TR. The identity of most of these proteins which form the receptor complexes which mediate transcriptional activation and basal repression still are not known. Our goal is to use techniques such as the yeast two-hybrid system and Far-Western analyses to identify nuclear proteins that interact with thyroid hormone receptors and steroid hormone receptors. We also plan to study the protein-protein interactions of identified co-factors with receptors using in vitro, cell culture, and histological approaches (particularly with green fluoroscent probes). We also will examine the interaction of these and previously described co-factors with natural mutant TRs from patients with thyroid hormone resistance syndrome. Additionally, in related work, we will study the action of mutant receptors in specific tissues (particularly adipose tissue) of transgenic mice which we previously have created. We also are targetting nuclear co-factors of thyroid hormone receptors to specific tissues in transgenic mice to understand their roles in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK055101-02
Application #
6105908
Study Section
Special Emphasis Panel (MCEB)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Rotman-Pikielny, Pnina; Hirschberg, Koret; Maruvada, Padma et al. (2002) Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum Mol Genet 11:2625-33
Yen, P M (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-142
Baumann, C T; Maruvada, P; Hager, G L et al. (2001) Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-45
Feng, X; Jiang, Y; Meltzer, P et al. (2001) Transgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferation. J Biol Chem 276:15066-72
Baumann, C T; Ma, H; Wolford, R et al. (2001) The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol 15:485-500
Ando, S; Sarlis, N J; Krishnan, J et al. (2001) Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15:1529-38
Ando, S; Sarlis, N J; Oldfield, E H et al. (2001) Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86:5572-6
Phillips, S A; Rotman-Pikielny, P; Lazar, J et al. (2001) Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant. J Clin Endocrinol Metab 86:5142-7